Hijazi, Z., Oldgren, J., Lindback, J., Alexander, J. H., Alings, M., De Caterina, R., … Wallentin, L. (2018). The Biomarker-Based ABC-Bleeding Risk Score Refines the Risk of Bleeding in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy. In CIRCULATION (Vol. 138).

Hijazi, Ziad, Jonas Oldgren, Johan Lindback, John H. Alexander, Marco Alings, Raffaele De Caterina, Claes Held, et al. “The Biomarker-Based ABC-Bleeding Risk Score Refines the Risk of Bleeding in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy.” In CIRCULATION, Vol. 138, 2018.

Hijazi Z, Oldgren J, Lindback J, Alexander JH, Alings M, De Caterina R, et al. The Biomarker-Based ABC-Bleeding Risk Score Refines the Risk of Bleeding in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy. In: CIRCULATION. 2018.

Hijazi, Ziad, et al. “The Biomarker-Based ABC-Bleeding Risk Score Refines the Risk of Bleeding in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy.” CIRCULATION, vol. 138, 2018.

Hijazi Z, Oldgren J, Lindback J, Alexander JH, Alings M, De Caterina R, Held C, Huber K, Hylek EM, Granger CB, Lopes RD, Vinereanu D, Siegbahn A, Wallentin L. The Biomarker-Based ABC-Bleeding Risk Score Refines the Risk of Bleeding in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy. CIRCULATION. 2018.